Happy to share my first PhD paper in Pharmacological Research 🎉
Using a Japanese claims database, we found that concomitant use of quetiapine and Bupleuri Radix (Chaihu)-containing formulations was associated with increased risk of acute adverse events.
https://t.co/qy8Stf8HLa
Our paper on trends in migraine-specific medication consumption across 73 countries is out now in Journal of Headache and Pain, as part of the collection “2026 Early Career Research Mentorship Program”. 🎉
🔗https://t.co/Ya0rqrmuX8
Researchers from HKUMed have conducted a series of landmark studies demonstrating that statins can lower the risk of cardiovascular disease without increasing the incidence of major adverse events.
https://t.co/QlweKMrg2K
Our study on repeated antibiotic prescribing in patients living with dementia. While we found no association with seizure or other neuropsychiatric disorders, repeated antibiotic courses were associated with an increased risk of all-cause hospitalization. https://t.co/MfxoeSOmok
In our #multinational study in @JInternMed, #statin initiation may be associated with increased risk of incident #MyastheniaGravis#MG during the first 6–12 months, with a greater magnitude of risk elevation for higher intensity of statin therapy.
https://t.co/V0t7QlR9a7
From #HongKong#Chronic Disease Co-Care Pilot Scheme #CDCC participants, our team found that #smoking, physical inactivity, and lower educational level were significant associated factors for #preDM, Type 2 #diabetes#T2DM, and #hypertension#HT. https://t.co/yYtlycaAaP
Our paper on @BMCMedicine provides an updated and comprehensive estimate of the #mortality and #morbidity burden associated with #smoking, using a 1.6 million cohort in Hong Kong.
https://t.co/iAeRe8lROj
Shorter durations of #antibiotic prophylaxis, including no prophylaxis, appear noninferior to longer durations for preventing mortality in patients with #cirrhosis and upper gastrointestinal bleeding.
https://t.co/JP2HEb70Gf
Our @AnnalsofIM paper found that #statins initiation associates with reductions of all-cause #mortality & #CVD in #T2DM adults, including low-risk groups. Results suggest statins initiation in T2DM adults even when short-term predicted CVD #risk is low.
https://t.co/SNCQlHgXVX
Our new study is out! We looked at anaemia treatments (ESAs) and fracture risk in CKD patients.
Prolonged ESA use seems linked to a higher risk of osteoporotic fractures. This suggests we need to optimise treatment to balance benefits vs. risk. Full text: https://t.co/h3GtofA46m
Happy to share our study on Pneumococcal disease epidemiology on International Journal of Infectious Diseases:
Children and adolescents had an elevated risk of gaining antimicrobial resistance, suggesting more measures to reduce S. pneumoniae infections
https://t.co/x0pvnqkL2q
Our multinational database study in @eClinicalMed
compared antihypertensive prescribing trends in Hong Kong, United Kingdom, Sweden, and Australia, providing evidence on the use of blood pressure-lowering drugs before and after a diagnosis of dementia.
https://t.co/CDKZL0dcQq
Our new meta-analysis in Hypertension Research confirms Sacubitril/Valsartan effectively reduces both office and out-of-office blood pressure.
This was a fantastic international collaboration with our colleagues at Chulalongkorn University.
https://t.co/gzOjOurHA4
Excited to share our latest study in @LancetRH_WPac : Psychotropic medication consumption increased globally after the onset of the COVID-19 pandemic, with variations in consumption patterns observed across different countries. @Esther_CSMPRHKU
https://t.co/umLRvID1Tl